Sjoukje van der Hoek

4PUBLICATIONS
6CO-AUTHORS
Molecular targetsMajor global burdens of diseaseBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 31, 2023
Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial.

Sjoukje van der Hoek, Niels Jongs, Megumi Oshima

|Mar 10, 2023
Feasibility Study to Assess Canagliflozin Distribution and Sodium-Glucose Co-Transporter 2 Occupancy Using [18 F]Canagliflozin in Patients with Type 2 Diabetes.

Sjoukje van der Hoek, Antoon T M Willemsen, Ton Visser

|Sep 07, 2022
Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [11 C]Telmisartan.

Sjoukje van der Hoek, Douwe J Mulder, Antoon T M Willemsen

|Nov 08, 2021
GMP Compliant Synthesis of [18F]Canagliflozin, a Novel PET Tracer for the Sodium-Glucose Cotransporter 2.

Sjoukje van der Hoek, Inês F Antunes, Khaled A Attia

Pageof 1

Frequent Collaborators

2 joint publications

Douwe J Mulder

2 joint publications

Jasper Stevens

1 joint publications

Inês F Antunes

1 joint publications

Philip H Elsinga